Radiation boost tested to fight spreading esophageal cancer
NCT ID NCT05978193
Summary
This study is testing if adding two types of radiation therapy to standard first-line treatment helps people with advanced esophageal cancer that has spread. About 100 adults who haven't had prior cancer treatment will be randomly assigned to receive either the standard immunotherapy-plus-chemotherapy or that same standard treatment plus radiation. The main goal is to see if the combination with radiation keeps the cancer from getting worse for a longer time and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Ruijin Hospital
RECRUITINGShanghai, 200020, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.